Andrea Busnelli

ORCID: 0000-0001-9870-5241 · 33 papers in corpus
2025
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.15050

IntroductionRecurrent pregnancy loss (RPL), defined as two or more consecutive pregnancy losses before 24 weeks of gestation, affects up to 1%-2% of couples. Aim of this retrospective cohort study was to report the main causes and pregnancy…

2025
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-024-03379-0

PurposeObesity is increasingly at the center of modern international healthcare systems. This is a position statement of the Italian Society of Fertility and Sterility and Reproductive Medicine (SIFES-MR) aimed at evaluating the impact of f…

2024
Mayo Clinic proceedings. Digital health ·doi:10.1016/j.mcpdig.2024.08.007

The aim of this systematic review was to identify clinical decision support algorithms (CDSAs) proposed for assisted reproductive technologies (ARTs) and to evaluate their effectiveness in improving ART cycles at every stage vs traditional …

2024
Frontiers in endocrinology ·doi:10.3389/fendo.2024.1535776

BackgroundReproductive success shows a well-documented decline with advancing maternal age, primarily due to chromosomal abnormalities (aneuploidies) in embryos. While ovarian reserve markers such as Anti-Müllerian Hormone (AMH) and Antral …

2024
Journal of ovarian research ·doi:10.1186/s13048-024-01372-w

BackgroundFollitropin delta is a novel recombinant follicle stimulating hormone preparation uniquely expressed in a human fetal retinal cell line by recombinant DNA technology. To date, no systematic review was available about the safety an…

2024
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-024-03197-4

PurposeThis position statement by the Italian Society of Fertility and Sterility and Reproductive Medicine (SIFES-MR) aims to establish an optimal framework for fertility preservation outside the standard before oncological therapies. Key t…

article 2024
·doi:10.1093/hropen/hoae007
other 2024
Human Reproduction ·doi:10.1093/humrep/deae148

STUDY QUESTION: What is the prevalence of congenital and acquired anomalies of the uterus in women with recurrent pregnancy loss (RPL) of unknown etiology examined using 3D transvaginal ultrasound (US)? SUMMARY ANSWER: Depending on the ado…

meta-analysis 2024
Human Reproduction Update ·doi:10.1093/humupd/dmae024

BACKGROUND: Women with endometriosis may constitute a group at a particularly increased risk of pregnancy-related complications. Furthermore, women selected for assisted reproductive technology (ART) are exposed to additional endocrinologic…

article 2024
·doi:10.1016/j.jmig.2024.07.013

ObjectiveTo provide available evidence comparing surgical outcomes of different vaginal hysterectomy (VH) techniques and devices.Data sourcesPubMed, Embase, and ClinicalTrials.gov databases were searched from inception to December 1, 2023, …

2023
Human reproduction open ·doi:10.1093/hropen/hoad026

Study questionDo low levels of anti-Müllerian hormone (AMH) or antral follicle count (AFC) properly predict miscarriage in young women conceiving with ART?Summary answerLow ovarian reserve, as indicated by AMH or AFC, is not associated with…

2023
Frontiers in endocrinology ·doi:10.3389/fendo.2023.1251866

BackgroundPublished data on the relationship between polycystic ovary syndrome (PCOS) and thyroid dysfunction are sparse and confusing.ObjectiveTo comprehensively review data available in the literature regarding the relationship between PC…

2022
Scientific reports ·doi:10.1038/s41598-022-24649-w

The present retrospective study included both intrauterine insemination and in vitro assisted reproductive technologies (ART) procedures performed from January 2009 to December 2018 at a tertiary-care Fertility Centre. The purpose was to as…

article 2022
·doi:10.1093/humrep/deac104.043

Abstract Study question We aimed to verify whether endometriosis patients who succeeded in achieving a live birth through IVF were epigenetically younger than those who did not. Summary answer Applying peripheral blood epigenetic clock, end…

2022
PloS one ·doi:10.1371/journal.pone.0261591

ObjectiveTo evaluate whether telomere length (TL), mitochondrial-DNA (mt-DNA) or epigenetic age estimators based on DNA methylation (DNAm) pattern could be considered reliable predictors of in-vitro-fertilization (IVF) success in terms of l…

article 2022
·doi:10.31083/j.ceog4902043

Background: In the context of extragenital endometriosis, the gastrointestinal, urinary tract, abdominal wall, and thorax localizations are considered relatively frequent, while the umbilical, inguinal, sciatic nerve, liver, and pancreas ar…

2022
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-021-02362-3

PurposeTo assess whether live birth rates (LBR) and maternal/neonatal complications differed following single fresh and frozen-warmed blastocyst transfer.MethodsThe present retrospective observational study analyzed 4,613 single embryo tran…

article 2021
·doi:10.1016/j.fertnstert.2021.07.673
article 2020
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-019-00068-7

Several pathogenetic mechanisms have been postulated to explain the association between endometriosis and subfertility. However, to date, definitive conclusions cannot be drawn. In this study, we hypothesized that the reduced exploitation o…

article 2020
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-019-00070-z

A consistent body of in vitro evidence supports a detrimental effect of endometriosis on ovarian steroidogenesis, in particular the synthesis of estrogens. However, clinical evidence is scanty and methodologically weak. This study aimed at …

article 2019
European journal of obstetrics & gynecology and reproductive biology: X ·doi:10.1016/j.eurox.2019.100073

OBJECTIVE: Ovarian hyper-stimulation during IVF is associated with a significant raise in serum estrogens and one may expect detrimental effects on estrogen-dependent diseases such as endometriosis. However, available evidence from large ca…

article 2018
Human Reproduction ·doi:10.1093/humrep/dey368

Elagolix, an orally active non-peptidic GnRH antagonist, has been approved by the Food and Drug Administration for the management of moderate to severe pain associated with endometriosis. As the degree of ovarian suppression obtained with e…

other 2018
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2018.03.020

RESEARCH QUESTION: What are the frequency, characteristics and consequences of technical diffiiculties encountered by physicians when carrying out oocyte retrieval in women with ovarian endometriomas? DESIGN: We prospectively recruited wom…

review 2018
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2018.11.021

Available evidence on the impact of ovarian stimulation on the progression of endometriosis or its recurrence was systematically reviewed. Data from ovarian stimulation alone, or associated with intrauterine insemination (IUI) or IVF, were …

2017
Human reproduction (Oxford, England) ·doi:10.1093/humrep/dex032

In the last decade, testosterone replacement therapy (TRT) has been increasingly prescribed to treat a controversial condition known as 'late-onset hypogonadism (LOH)'. This syndrome is diagnosed in men who, for no discernible reason other …